• ISBN13: 9780824719272
• Binding: Hardcover
• Subject: Medical, Nursing and Health Sciences
• Publisher: T&F
• Publisher Imprint: Mar Dekker
• Publication Date: June 16, 1999
• Pages: 241
• Original Price: GBP 123.0
• Language: English
• Edition: N/A
• Item Weight: 500 grams

About the Book These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process. <br>Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employed in the creation of vital new cardiovascular therapies <br>Cardiovascular Drug Development<br><li>explores the delicate balance of efficacy and safety that cardiovascular therapy must achieve to gain regulatory approval <br></li><li>discusses the search for surrogates and the need in some areas for natural history endpoints <br></li><li>reviews optimum strategies for protocol design in the development of drugs to treat hypertension, cardiac arrhythmias, heart failure, coronary artery disease, and hypercholesterolemia and other lipid disorders <br></li><li>compares and contrasts the varying standards of evidence for drug approval in the United States, Europe, and Asia <br></li><li>and more <br>Cardiovascular Drug Development will prove to be a valuable asset for cardiologists, pharmacologists and pharmacists, regulatory affairs specialists, and directors of research and development for pharmaceutical companies.</li>